Metabolic disorders and breast cancer risk (United States)

Objective: To clarify the hormonal context of breast cancer etiology we used data from a large, population-based case–control study to investigate the relationship between breast cancer risk and a history of diabetes mellitus, disorders associated with estrogen stimulation (uterine fibroids, endometriosis, gallstones), and disorders associated with androgen stimulation (acne, hirsutism, and polycystic ovaries). Methods: Breast cancer patients between 50 and 75 years old were identified from state-wide tumor registries in Wisconsin, Massachusetts, and New Hampshire; controls were randomly selected from drivers' license lists (age less than 65) or Medicare enrollment files (age 65–74). Information on reproductive history, medical history, and personal habits was obtained by telephone interview. A total of 5659 cases and 5928 controls were interviewed and provided suitable data. Results: There was no overall association between breast cancer risk and reported history of diabetes mellitus, endometriosis, uterine fibroids, gallstones, or cholecystectomy. However, the disorders with androgenic associations all conferred an increased risk: the overall odds ratio (OR) for a history of acne was 1.4 (95% CI 1.0–1.9), that for hirsutism was 1.2 (95% CI 0.81–1.8), and that for polycystic ovaries 1.6 (95% CI 0.8–3.2). Diabetes mellitus diagnosed before age 35 conferred an odds ratio of 0.52 (95% 0.25–1.1), while diabetes diagnosed at a later age was associated with an increased risk (OR = 1.2, 95% CI 1.0–1.4). Conclusions: Androgen-related phenomena are likely to be important in the etiology of breast cancer. Similar content being viewed by others

Henderson B, Pike M, Bernstein L, Ross R (1996) Breast cancer, 2nd edn. New York: Oxford University Press. Kaaks R (1996) Nutrition, hormones, and breast cancer: is insulin the missing link? Cancer Causes Control 7: 605-625. Koutsilieris M (1992) Pathophysiology of uterine leiomyomas. Biochem Cell Biol 70: 273-278. Barbieri RL (1990) Etiology and epidemiology of endometriosis. Am J Obstet Gynecol 162: 565-567. Everson GT, McKinley C, Kern F, Jr (1991) Mechanisms of gallstone formation in women. Effects of exogenous estrogen (Premarin) and dietary cholesterol on hepatic lipid metabolism. J Clin Invest 87: 237-246. Franks S (1995) Polycystic ovary syndrome. N Engl J Med 333: 853-861. Lucky AW (1995) Hormonal correlates of acne and hirsutism. Am J Med 98: 89S-94S. Weir G, Leahy J (1994) Pathogenesis of Non-insulin-dependent (Type II) Diabetes Mellitus, 13th edn. Philadelphia: Lea & Febiger. Damewood MD (1993) Pathophysiology and management of endometriosis. J Fam Pract 37: 68-75. Stampfer MJ, Maclure KM, Colditz GA, et al. (1992) Risk of symptomatic gallstones in women with severe obesity. Am J Clin Nutr 55: 652-658. Marshall LM, Spiegelman D, Manson JE, et al. (1998) Risk of uterine leiomyomata among premenopausal women in relation to body size and cigarette smoking. Epidemiology 9: 511-517. Baron JA, La Vecchia C, Levi F (1990) The antiestrogenic effect of cigarette smoking in women. Am J Obstet Gynecol 162: 502-514. La Vecchia C, Franceschi S, Gallus G, et al. (1982) Oestrogens and obesity as risk factors for endometrial cancer in Italy. Int J Epidemiol 11: 120-126. McPherson CP, Sellers TA, Potter JD, et al. (1996) Reproductive factors and risk of endometrial cancer. The Iowa Women's Health Study. Am J Epidemiol 143: 1195-1202. Brinton LA, Berman ML, Mortel R, et al. (1992) Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control study. Am J Obstet Gynecol 167: 1317-1325. Weiss NS, Farewall VT, Szekely DR, et al. (1980) Oestrogens and endometrial cancer: effect of other risk factors on the association. Maturitas 2: 185-190. Brinton LA, Gridley G, Persson I, et al. (1997) Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol 176: 572-579. Schairer C, Persson I, Falkeborn M, et al. (1997) Breast cancer risk associated with gynecologic surgery and indications for such surgery. Int J Cancer 70: 150-154. Lindegard B (1990) Breast cancer among women from Gothenburg with regard to age, mortality and coexisting benign breast disease or leiomyoma uteri. Oncology 47: 369-375. Weiss HA, Brinton LA, Potischman NA, et al. (1999) Breast cancer risk in young women and history of selected medical conditions. Int J Epidemiol 28: 816-823. Franceschi S, la Vecchia C, Negri E, et al. (1990) Breast cancer risk and history of selected medical conditions linked with female hormones. Eur J Cancer 26: 781-785. Moseson M, Koenig KL, Shore RE, Pasternack BS (1993) The influence of medical conditions associated with hormones on the risk of breast cancer. Int J Epidemiol 22: 1000-1009. Talamini R, Franceschi S, Favero A, et al. (1997) Selected medical conditions and risk of breast cancer. Br J Cancer 75: 1699-1703. Johansen C, Chow WH, Jorgensen T, et al. (1996) Risk of colorectal cancer and other cancers in patients with gall stones. Gut 39: 439-443. Wysowski DK, Goldberg EL, Comstock GW, Diamond EL (1986) A study of a possible association between breast cancer and gallbladder disease. Am J Epidemiol 123: 532-543. Adami HO, Meirik O, Gustavsson S, et al. (1984) Cholecystectomy and the incidence of breast cancer: a cohort study. Br J Cancer 49: 235-239. Kato I, Miura S, Yoshida M, Tominaga S (1986) Risk factors of multiple primary cancers in breast cancer patients. Jpn J Cancer Res 77: 296-304. Riggs BL, Khosla S, Melton LJ, 3rd (1998) A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res 13: 763-773. Persson I, Adami HO, McLaughlin JK, et al. (1994) Reduced risk of breast and endometrial cancer among women with hip fractures (Sweden). Cancer Causes Control 5: 523-528. Zhang Y, Kiel DP, Kreger BE, et al. (1997) Bone mass and the risk of breast cancer among postmenopausal women. N Engl J Med 336: 611-617. Cauley JA, Lucas FL, Kuller LH, et al. (1996) Bone mineral density and risk of breast cancer in older women: the study of ostcoporotic fractures. JAMA 276: 1404-1408. Cauley JA, Lucas FL, Kuller LH, et al. (1999) Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Ann Intern Med 130: 270-277. Berrino F, Muti P, Micheli A, et al. (1996) Serum sex hormone levels after menopause and subsequent breast cancer. J Nat Cancer Inst 88: 291-296. Toniolo PG, Levitz M, Zeleniuch-Jacquotte A, et al. (1995) A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Nat Cancer Inst 87: 190-197. Key TJ, Pike MC (1988) The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 24: 29-43. Carmina E, Lobo RA (1993) Evidence for increased androsterone metabolism in some normoandrogenic women with acne. J Clin Endocrinol Metab 76: 1111-1114. Leyden J (1993) New understanding of the pathogenesis of acne. J Am Acad Dermatol 32: S15-25. O'Rahilly R, Muller F (1992) Human Embryology and Teratology. New York: Wiley-Liss. Dorgan JF, Stanczyk FZ, Longcope C, et al. (1997) Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate, and 5-androstene-3 beta,17 beta-diol to risk of breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev 6: 177-181. Zeleniuch-Jacquotte A, Bruning PF, Bonfrer JM, et al. (1997) Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women. Am J Epidemiol 145: 1030-1038. Thomas HV, Key TJ, Allen DS, et al. (1997) A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the island of Guernsey. Br J Cancer 76: 401-405. Hankinson SE, Willett WC, Manson JE, et al. (1998) Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Nat Cancer Inst 90: 1292-1299. Krant MJ, Brandrup CS, Greene RS, et al. (1968) Sebaceous gland activity in breast cancer. Nature 217: 463-465. Burton JL, Cunliffe WJ, Shuster S (1970) Increased sebum excretion in patients with breast cancer. Br Med J 1: 665-666. Goolamali SK, Shuster S (1975) A sebotrophic stimulus in benign and malignant breast disease. Lancet 1: 428-429. Viladiu P, Izquierdo A, de Sanjose S, Bosch FX (1996) A breast cancer case-control study in Girona, Spain. Endocrine, familial and lifestyle factors. Eur J Cancer Prev 5: 329-335. Anderson KE, Sellers TA, Chen PL. et al. (1997) Association of Stein-Leventhal syndrome with the incidence of postmenopausal breast carcinoma in a large prospective study of women in Iowa. Cancer 79: 494-499. Gammon MD, Thompson WD (1991) Polycystic ovaries and the risk of breast cancer. Am J Epidemiol 134: 818-824. Coulam CB, Annegers JF, Kranz JS (1983) Chronic anovulation syndrome and associated neoplasia. Obstet Gynecol 61: 403-407. Haffner SM, Miettinen H (1997) Insulin resistance implications for type II diabetes mellitus and coronary heart disease. Am J Med 103: 152-162. Stoll BA (1993) The growth hormone/insulin-like growth factor axis and breast cancer risk Breast 2: 130-133. Nestler JE, Strauss JFD (1991) Insulin as an effector of human ovarian and adrenal steriod metabolism. Endocrinol Metab Clin N Am 20: 807-823. Weiderpass E, Gridley G, Persson I, et al. (1997) Risk of endometrial and breast cancer in patients with diabetes mellitus Int J Cancer 71: 360-363. Wideroff L, Gridley G, Persson I, et al. (1997) Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Nat Cancer Inst 89: 1360-1365. Stoll BA (1994) Breast cancer: the obesity connection. Br J Cancer 69: 799-801. Kazer RR (1995) Insulin resistance, insulin-like growth factor I and breast cancer: a hypothesis. Int J Cancer 62: 403-406. de Klerk NH, English DR, Armstrong BK (1989) A review of the effects of random measurement error on relative risk estimates in epidemiological studies. Int J Epidemiol 18: 705-712. Author information Authors and Affiliations Rights and permissions About this article Cite this article Baron, J.A., Weiderpass, E., Newcomb, P.A. et al. Metabolic disorders and breast cancer risk (United States). Cancer Causes Control 12, 875–880 (2001). https://doi.org/10.1023/A:1013796112348 Issue date: DOI: https://doi.org/10.1023/A:1013796112348